Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REHCO is a private holding and investment company based in Oklahoma City, Oklahoma. Publicly available information indicates that it invests across diverse industries, geographies, and asset classes rather than operating as a biotechnology, pharmaceutical, or healthcare developer. REHCO has been associated with investment activity and board participation in multiple portfolio companies, including historical involvement with Synereca Pharmaceuticals through one of its partners. Available business-directory data suggests it is a small private company with limited public disclosure. Based on the evidence reviewed, REHCO does not appear to be a life sciences operating company with a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REHCO.